PMID- 34389477 OWN - NLM STAT- MEDLINE DCOM- 20211025 LR - 20211025 IS - 1873-2763 (Electronic) IS - 1873-2763 (Linking) VI - 153 DP - 2021 Dec TI - Development of a bioactive and radiopaque bismuth doped baghdadite ceramic for bone tissue engineering. PG - 116147 LID - S8756-3282(21)00313-6 [pii] LID - 10.1016/j.bone.2021.116147 [doi] AB - Baghdadite (Ca(3)ZrSi(2)O(9), BAG), is a Zr-doped calcium silicate that has outstanding bioactivity both in vitro and in vivo. Bioceramic scaffolds should be sufficiently radiopaque to be distinguishable in vivo from surrounding bone structures. To enhance the radiopacity of BAG, this study investigated the effect of incorporating bismuth ions into its crystalline structure (Bi(x)Ca(3-x)ZrSi(2)O(9), x = 0, 0.1, 0.2, 0.5; BAG, Bi0.1-BAG, Bi0.2-BAG, Bi0.5-BAG, respectively). Monophasic baghdadite was retained after bismuth ion incorporation up to x = 0.2 at calcination temperatures of 1350 degrees C. When pressed and sintered, energy dispersive x-ray spectroscopy showed that BAG and Bi0.1-BAG retained crystalline homogeneity, but Bi0.2-BAG formed zirconium-rich crystalline regions. BAG, Bi0.1-BAG and Bi0.2-BAG exhibited non-degradation after 56 days of immersion in culture medium. Bi0.1-BAG exhibited the lowest change in culture medium pH (+0.0), compared to BAG (+0.7) and Bi0.2-BAG (+0.2) after 56 days of culture media immersion. Bi0.1-BAG exhibited similar strength and modulus to BAG (sigma: 200-290 MPa; E: 4-5 GPa), and significantly higher compressive strength and modulus versus Bi0.2-BAG (sigma: 150-200 MPa; E: 3.5-4 GPa) across 56 days of aqueous immersion. In vitro studies using primary human bone derived cells (HOBs) demonstrated a significant increase in HOBs proliferation when cultured on Bi0.1-BAG for seven days compared to BAG and Bi0.2-BAG. Importantly, Bi0.1-BAG showed increased radiopacity by ~33%, when compared to BAG, and by ~115% when compared to biphasic calcium phosphate. The properties of Bi0.1-BAG show promise for its use as a bioactive ceramic with sufficient radiopacity for treatment of bone defects. CI - Copyright (c) 2021 Elsevier Inc. All rights reserved. FAU - No, Young Jung AU - No YJ AD - Tissue Engineering & Biomaterials Research Unit, School of Biomedical Engineering, The University of Sydney, NSW 2006, Australia; ARC Training Centre for Innovative BioEngineering, The University of Sydney, NSW 2006, Australia. Electronic address: young.no@sydney.edu.au. FAU - Nguyen, Tien AU - Nguyen T AD - Tissue Engineering & Biomaterials Research Unit, School of Biomedical Engineering, The University of Sydney, NSW 2006, Australia; ARC Training Centre for Innovative BioEngineering, The University of Sydney, NSW 2006, Australia. FAU - Lu, Zufu AU - Lu Z AD - Tissue Engineering & Biomaterials Research Unit, School of Biomedical Engineering, The University of Sydney, NSW 2006, Australia; ARC Training Centre for Innovative BioEngineering, The University of Sydney, NSW 2006, Australia. FAU - Mirkhalaf, Mohammad AU - Mirkhalaf M AD - Tissue Engineering & Biomaterials Research Unit, School of Biomedical Engineering, The University of Sydney, NSW 2006, Australia; ARC Training Centre for Innovative BioEngineering, The University of Sydney, NSW 2006, Australia. FAU - Fei, Frank AU - Fei F AD - Tissue Engineering & Biomaterials Research Unit, School of Biomedical Engineering, The University of Sydney, NSW 2006, Australia; ARC Training Centre for Innovative BioEngineering, The University of Sydney, NSW 2006, Australia. FAU - Foley, Matthew AU - Foley M AD - Australian Centre for Microscopy & Microanalysis, The University of Sydney, NSW 2006, Australia. FAU - Zreiqat, Hala AU - Zreiqat H AD - Tissue Engineering & Biomaterials Research Unit, School of Biomedical Engineering, The University of Sydney, NSW 2006, Australia; ARC Training Centre for Innovative BioEngineering, The University of Sydney, NSW 2006, Australia. Electronic address: hala.zreiqat@sydney.edu.au. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20210811 PL - United States TA - Bone JT - Bone JID - 8504048 RN - 0 (Ca(3)ZrSi(2)O(9)) RN - 0 (Silicates) RN - U015TT5I8H (Bismuth) SB - IM MH - *Bismuth MH - Ceramics MH - Compressive Strength MH - Humans MH - Silicates MH - *Tissue Engineering MH - Tissue Scaffolds OTO - NOTNLM OT - Bioactive ceramic OT - In vitro characterisation OT - Radiopacity OT - Synthetic bone grafts EDAT- 2021/08/15 06:00 MHDA- 2021/10/26 06:00 CRDT- 2021/08/14 05:46 PHST- 2021/05/30 00:00 [received] PHST- 2021/07/27 00:00 [revised] PHST- 2021/08/06 00:00 [accepted] PHST- 2021/08/15 06:00 [pubmed] PHST- 2021/10/26 06:00 [medline] PHST- 2021/08/14 05:46 [entrez] AID - S8756-3282(21)00313-6 [pii] AID - 10.1016/j.bone.2021.116147 [doi] PST - ppublish SO - Bone. 2021 Dec;153:116147. doi: 10.1016/j.bone.2021.116147. Epub 2021 Aug 11.